Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.19 USD | +0.63% | +1.60% | +11.62% |
09/05 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
17/04 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.62% | 12Cr | |
+9.14% | 11TCr | |
+11.46% | 10TCr | |
-12.93% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-3.45% | 1.79TCr | |
+8.14% | 1.43TCr | |
+34.79% | 1.25TCr |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- Craig Hallum Lowers DiaMedica Therapeutics' Price Target to $12 From $18, Keeps Buy Rating